183 related articles for article (PubMed ID: 30657702)
1. High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics.
Ben-Yakar A
Assay Drug Dev Technol; 2019 Jan; 17(1):8-13. PubMed ID: 30657702
[TBL] [Abstract][Full Text] [Related]
2. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
Youssef K; Tandon A; Rezai P
Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic systems for high-throughput and high-content screening using the nematode Caenorhabditis elegans.
Cornaglia M; Lehnert T; Gijs MAM
Lab Chip; 2017 Nov; 17(22):3736-3759. PubMed ID: 28840220
[TBL] [Abstract][Full Text] [Related]
4. Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model.
Mondal S; Hegarty E; Martin C; Gökçe SK; Ghorashian N; Ben-Yakar A
Nat Commun; 2016 Oct; 7():13023. PubMed ID: 27725672
[TBL] [Abstract][Full Text] [Related]
5. Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and
Yoon S; Kilicarslan You D; Jeong U; Lee M; Kim E; Jeon TJ; Kim SM
Biosensors (Basel); 2024 Jan; 14(1):. PubMed ID: 38275308
[TBL] [Abstract][Full Text] [Related]
6. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery: Insights from the invertebrate Caenorhabditis elegans.
Giunti S; Andersen N; Rayes D; De Rosa MJ
Pharmacol Res Perspect; 2021 Apr; 9(2):e00721. PubMed ID: 33641258
[TBL] [Abstract][Full Text] [Related]
8. C. elegans in high-throughput drug discovery.
O'Reilly LP; Luke CJ; Perlmutter DH; Silverman GA; Pak SC
Adv Drug Deliv Rev; 2014 Apr; 69-70():247-53. PubMed ID: 24333896
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances and Trends in Microfluidic Platforms for C. elegans Biological Assays.
Kamili F; Lu H
Annu Rev Anal Chem (Palo Alto Calif); 2018 Jun; 11(1):245-264. PubMed ID: 29894230
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic Technologies for High Throughput Screening Through Sorting and On-Chip Culture of
Midkiff D; San-Miguel A
Molecules; 2019 Nov; 24(23):. PubMed ID: 31775328
[TBL] [Abstract][Full Text] [Related]
11. An automated compound screening for anti-aging effects on the function of C. elegans sensory neurons.
Bazopoulou D; Chaudhury AR; Pantazis A; Chronis N
Sci Rep; 2017 Aug; 7(1):9403. PubMed ID: 28839194
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic in vivo screen identifies compounds enhancing neuronal regeneration.
Rohde CB; Gilleland C; Samara C; Norton S; Haggarty S; Yanik MF
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():5950-2. PubMed ID: 19965065
[TBL] [Abstract][Full Text] [Related]
13. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
Kim W; Hendricks GL; Lee K; Mylonakis E
Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
[TBL] [Abstract][Full Text] [Related]
14. The Ancient Genetic Networks of Obesity: Whole-Animal Automated Screening for Conserved Fat Regulators.
Ke W; Drangowska-Way A; Katz D; Siller K; O'Rourke EJ
Methods Mol Biol; 2018; 1787():129-146. PubMed ID: 29736715
[TBL] [Abstract][Full Text] [Related]
15. An integrated microfluidic platform for evaluating in vivo antimicrobial activity of natural compounds using a whole-animal infection model.
Yang J; Chen Z; Ching P; Shi Q; Li X
Lab Chip; 2013 Sep; 13(17):3373-82. PubMed ID: 23824379
[TBL] [Abstract][Full Text] [Related]
16. Detecting and Trapping of a Single C. elegans Worm in a Microfluidic Chip for Automated Microplate Dispensing.
Desta IT; Al-Sharif A; AlGharibeh N; Mustafa N; Orozaliev A; Giakoumidis N; Gunsalus KC; Song YA
SLAS Technol; 2017 Aug; 22(4):431-436. PubMed ID: 27630097
[TBL] [Abstract][Full Text] [Related]
17. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z.
Gosai SJ; Kwak JH; Luke CJ; Long OS; King DE; Kovatch KJ; Johnston PA; Shun TY; Lazo JS; Perlmutter DH; Silverman GA; Pak SC
PLoS One; 2010 Nov; 5(11):e15460. PubMed ID: 21103396
[TBL] [Abstract][Full Text] [Related]
18. High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model.
Mondal S; Hegarty E; Sahn JJ; Scott LL; Gökçe SK; Martin C; Ghorashian N; Satarasinghe PN; Iyer S; Sae-Lee W; Hodges TR; Pierce JT; Martin SF; Ben-Yakar A
ACS Chem Neurosci; 2018 May; 9(5):1014-1026. PubMed ID: 29426225
[TBL] [Abstract][Full Text] [Related]
19. High-throughput small-molecule screening in Caenorhabditis elegans.
Rangaraju S; Solis GM; Petrascheck M
Methods Mol Biol; 2015; 1263():139-55. PubMed ID: 25618342
[TBL] [Abstract][Full Text] [Related]
20. Multimodal imaging and high-throughput image-processing for drug screening on living organisms on-chip.
Migliozzi D; Cornaglia M; Mouchiroud L; Uhlmann V; Unser MA; Auwerx J; Gijs MAM
J Biomed Opt; 2018 Nov; 24(2):1-9. PubMed ID: 30484295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
